NYSE:PBH - Prestige Consumer Healthcare Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $28.52 +0.01 (+0.04 %) (As of 02/18/2019 02:21 PM ET)Previous Close$28.51Today's Range$28.47 - $29.2152-Week Range$26.25 - $41.76Volume445,571 shsAverage Volume623,587 shsMarket Capitalization$1.48 billionP/E Ratio11.05Dividend YieldN/ABeta0.91 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. The company's OTC healthcare products include BC/Goody's analgesic powders, Beano for gas prevention, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergy/redness relief, Compound W for wart removal, Debrox for ear wax removal, DenTek PEG oral care, Dramamine for motion sickness relief, and Efferdent denture cleanser tablets. Its OTC healthcare products portfolio also comprises Fess nasal saline spray, Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Hydralyte for oral rehydration, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Pedia-Lax pediatric laxatives, Summer's Eve for feminine hygiene, Little Remedies pediatric OTC products, and The Doctor's NightGuard dental protectors. In addition, the company offers household cleaning products, such as abrasive tub and tile cleaners under the Comet name, as well as Chore Boy, and Spic and Span names. It serves mass merchandisers; and drug, food, dollar, convenience, and club stores. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. Receive PBH News and Ratings via Email Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Pharmaceutical preparations Sub-IndustryPersonal Products SectorConsumer Discretionary Current SymbolNYSE:PBH Previous Symbol CUSIP74112D10 Webwww.prestigebrands.com Phone914-524-6800Debt Debt-to-Equity Ratio1.49 Current Ratio2.28 Quick Ratio1.34Price-To-Earnings Trailing P/E Ratio11.05 Forward P/E Ratio10.30 P/E Growth1.66 Sales & Book Value Annual Sales$1.04 billion Price / Sales1.42 Cash Flow$3.3396 per share Price / Cash Flow8.54 Book Value$23.81 per share Price / Book1.20Profitability EPS (Most Recent Fiscal Year)$2.58 Net Income$339.57 million Net Margins6.44% Return on Equity11.85% Return on Assets3.79%Miscellaneous Employees530 Outstanding Shares51,798,000Market Cap$1.48 billion OptionableOptionable Prestige Consumer Healthcare (NYSE:PBH) Frequently Asked Questions What is Prestige Consumer Healthcare's stock symbol? Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH." How were Prestige Consumer Healthcare's earnings last quarter? Prestige Consumer Healthcare Inc (NYSE:PBH) posted its quarterly earnings data on Thursday, February, 7th. The company reported $0.73 EPS for the quarter, beating the Zacks' consensus estimate of $0.71 by $0.02. The firm had revenue of $241.40 million for the quarter, compared to the consensus estimate of $241.40 million. Prestige Consumer Healthcare had a net margin of 6.44% and a return on equity of 11.85%. The firm's revenue was down 10.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.70 EPS. View Prestige Consumer Healthcare's Earnings History. When is Prestige Consumer Healthcare's next earnings date? Prestige Consumer Healthcare is scheduled to release their next quarterly earnings announcement on Thursday, May 9th 2019. View Earnings Estimates for Prestige Consumer Healthcare. What guidance has Prestige Consumer Healthcare issued on next quarter's earnings? Prestige Consumer Healthcare issued an update on its FY19 earnings guidance on Thursday, February, 7th. The company provided EPS guidance of $2.75-$2.78 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.76. The company issued revenue guidance of $970-$975 million, compared to the consensus revenue estimate of $971.99 million.Prestige Consumer Healthcare also updated its FY 2019 guidance to $2.75-2.78 EPS. What price target have analysts set for PBH? 4 equities research analysts have issued 12-month target prices for Prestige Consumer Healthcare's shares. Their forecasts range from $28.40 to $88.00. On average, they anticipate Prestige Consumer Healthcare's share price to reach $48.10 in the next year. This suggests a possible upside of 68.7% from the stock's current price. View Analyst Price Targets for Prestige Consumer Healthcare. What is the consensus analysts' recommendation for Prestige Consumer Healthcare? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Prestige Consumer Healthcare. Has Prestige Consumer Healthcare been receiving favorable news coverage? Media headlines about PBH stock have been trending somewhat positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Prestige Consumer Healthcare earned a media sentiment score of 1.6 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. Who are some of Prestige Consumer Healthcare's key competitors? Some companies that are related to Prestige Consumer Healthcare include Amarin (AMRN), GALAPAGOS NV/S (GLPG), United Therapeutics (UTHR), Patheon (PTHN), Alkermes (ALKS), Array Biopharma (ARRY), FibroGen (FGEN), GW Pharmaceuticals PLC- (GWPH), Taro Pharmaceutical Industries (TARO), TESARO (TSRO), Amneal Pharmaceuticals (AMRX), Horizon Pharma (HZNP), Agios Pharmaceuticals (AGIO), HUTCHISON CHINA/S (HCM) and Evotec (EVTCY). Who are Prestige Consumer Healthcare's key executives? Prestige Consumer Healthcare's management team includes the folowing people: Mr. Ronald M. Lombardi, Chairman, Pres & CEO (Age 55)Ms. Christine Sacco, Chief Financial Officer (Age 43)Mr. William C. P'Pool, Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)Mr. Timothy J. Connors, Exec. VP of Sales & Marketing (Age 52)Mr. Jeff Zerillo, Sr. VP of Operations Who are Prestige Consumer Healthcare's major shareholders? Prestige Consumer Healthcare's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.48%), Dimensional Fund Advisors LP (7.82%), Macquarie Group Ltd. (2.79%), Fisher Asset Management LLC (2.41%), Acadian Asset Management LLC (2.39%) and Northern Trust Corp (1.65%). Company insiders that own Prestige Consumer Healthcare stock include Gary E Costley, Jean A Boyko, Natale S Ricciardi, Ronald M Lombardi, Timothy Connors and William P'pool. View Institutional Ownership Trends for Prestige Consumer Healthcare. Which major investors are selling Prestige Consumer Healthcare stock? PBH stock was sold by a variety of institutional investors in the last quarter, including Standard Life Aberdeen plc, Bank of America Corp DE, Prudential Financial Inc., Nuveen Asset Management LLC, Fiera Capital Corp, Foresters Investment Management Company Inc., Barclays PLC and Principal Financial Group Inc.. Company insiders that have sold Prestige Consumer Healthcare company stock in the last year include Jean A Boyko and Timothy Connors. View Insider Buying and Selling for Prestige Consumer Healthcare. Which major investors are buying Prestige Consumer Healthcare stock? PBH stock was bought by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, LSV Asset Management, BlackRock Inc., Acadian Asset Management LLC, Macquarie Group Ltd., State of Tennessee Treasury Department, D. E. Shaw & Co. Inc. and Millennium Management LLC. Company insiders that have bought Prestige Consumer Healthcare stock in the last two years include Gary E Costley, Natale S Ricciardi, Ronald M Lombardi and William P'pool. View Insider Buying and Selling for Prestige Consumer Healthcare. How do I buy shares of Prestige Consumer Healthcare? Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Prestige Consumer Healthcare's stock price today? One share of PBH stock can currently be purchased for approximately $28.52. How big of a company is Prestige Consumer Healthcare? Prestige Consumer Healthcare has a market capitalization of $1.48 billion and generates $1.04 billion in revenue each year. The company earns $339.57 million in net income (profit) each year or $2.58 on an earnings per share basis. Prestige Consumer Healthcare employs 530 workers across the globe. What is Prestige Consumer Healthcare's official website? The official website for Prestige Consumer Healthcare is http://www.prestigebrands.com. How can I contact Prestige Consumer Healthcare? Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected] MarketBeat Community Rating for Prestige Consumer Healthcare (NYSE PBH)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 376 (Vote Outperform)Underperform Votes: 273 (Vote Underperform)Total Votes: 649MarketBeat's community ratings are surveys of what our community members think about Prestige Consumer Healthcare and other stocks. Vote "Outperform" if you believe PBH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/18/2019 by MarketBeat.com StaffFeatured Article: What is Depreciation?